Chieh-Ju Lee

Chieh-Ju Lee has held several roles in the biotechnology industry since 2013. In 2013, they worked as an Industrialization Engineer at bioMérieux, where they were responsible for process development for scale up products, change control to existing products/processes product, and creating and presenting reports on conducted experiments. In 2014, they moved to HD Biosciences Co., Ltd. as an Associate Director, where they provided technical lead for humanized antibody discovery using phage display platform. In 2018, they joined Viva Biotech (Shanghai) Ltd. as an Associate Director, providing technical lead for humanized antibody discovery and antibody maturation using phage display and hybridoma platform. In 2019, they moved to Jing Medicine as an Associate Director, providing technical lead for antibody discovery platform and Ab Fc engineering to remove ADCC and drug developability analysis. Currently, they work at Full-Life Technologies as a Senior Director, collaborating with global biopharma companies for antibody and peptide drug discovery platforms.

Chieh-Ju Lee obtained a Bachelor's degree in Medical Technology from China Medical University between 1998 and 2002. Chieh-Ju then went on to obtain a Master's degree in Biology Anatomy from National Defense University between 2006 and 2008. Finally, they completed their Doctor of Philosophy - PhD in Biochemistry at the University of Sussex between 2009 and 2014.